| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 09/26/2006 | US7112598 κ opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 09/26/2006 | US7112597 5-(Substituted thiazolylethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/26/2006 | US7112590 Anticoagulant for mammals |
| 09/26/2006 | US7112413 Improved enzymatically-cleavable, chemiluminescent 1,2-dioxetanes containing enzymatically removable labile groups which allows decomposition; qualitative and quantitative analysis for bioassays; half life; kinetics |
| 09/21/2006 | WO2006099410A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 09/21/2006 | WO2006098308A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | WO2006097809A2 Novel tyrosine derivatives |
| 09/21/2006 | WO2006097766A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |
| 09/21/2006 | WO2006097014A1 A process for preparing pramipexole |
| 09/21/2006 | US20060211863 Process for the preparation of opioid modulators |
| 09/21/2006 | US20060211860 Compounds for the treatment of Alzheimer's disease |
| 09/21/2006 | US20060211746 Desferrithiocin derivatives and methods of use thereof |
| 09/21/2006 | US20060211732 Hydroxamic acid derivatives as antibacterials |
| 09/21/2006 | US20060211704 2,4-Disubstituted thiazolyl derivatives |
| 09/21/2006 | US20060211697 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | CA2601884A1 Novel tyrosine derivatives |
| 09/21/2006 | CA2600508A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |
| 09/20/2006 | EP1701724A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 09/20/2006 | EP1701722A1 N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy¨]pentoxy}benzamidine 2 methansulfonic acid salt |
| 09/20/2006 | EP1549624A4 Inhibitors of fatty acid amide hydrolase |
| 09/20/2006 | EP1253145B1 Alkali metal salt of thiazolidine-2,4-dione derivatives |
| 09/20/2006 | EP1073648B1 12,13-modified epothilone derivatives |
| 09/20/2006 | CN1835937A Novel thiazoline derivatives as selective androgen receptor modulators (SARMS) |
| 09/20/2006 | CN1835914A New benzamides as PPAR[upsilon] modulators |
| 09/20/2006 | CN1834095A Nonnucleoside antivirus inhibitor, its prepn. and use |
| 09/20/2006 | CN1834092A Prepn. of pramipexole |
| 09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/19/2006 | US7109347 Inhibitor is an amino acid linked to a thiazolidine or a pyrrolidine group by a peptide bond, e.g., L-threo-isoleucylpyrrolidine, L-allo-isoleucylthiazolidine, L-allo-isoleucylpyrrolydine, L-glutamoylthiazolidine, L-glutamoylpyrrolidine, L-glutamoythiazolidine, L-glutamoylpyrrolidine and their salts |
| 09/19/2006 | US7109243 Inhibitors of cathepsin S |
| 09/19/2006 | US7109224 Acyl guanidine compounds and use thereof |
| 09/19/2006 | US7109223 neuroprotective effect; potent selective agonists of the EP4 subtype of prostaglandin E2 receptors |
| 09/19/2006 | US7109222 Thiazole or oxazole derivatives such as 5-(4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl)-indan-2-carboxylic acid; Hypercholesterolemia, hyperlipidemia, and diabetes |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7108987 Factors participating in degranulation of mast cells, DNAs encoding the same, method of screening of these factors and the inhibitors |
| 09/14/2006 | WO2006096584A1 Process for the preparation of substituted benzoxazole compounds |
| 09/14/2006 | WO2006095713A1 Inhibitor of plasminogen activator inhibitor-1 |
| 09/14/2006 | WO2006094682A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/14/2006 | WO2006081172A3 Compounds and compositions as protein kinase inhibitors |
| 09/14/2006 | WO2006034296A3 Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof |
| 09/14/2006 | WO2006003471A3 Process for the preparation of pramipexole by chiral chromatography |
| 09/14/2006 | US20060205952 Aminocarbonyl naphthol derivative, cyanonaphthol derivative, and method for producing them |
| 09/14/2006 | US20060205812 5-Amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 09/14/2006 | US20060205796 Method for treating pain or pruritis by administering opinoid receptor agonist comprising 2-phenylbenzothiazoling derivative |
| 09/14/2006 | US20060205785 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/14/2006 | US20060205773 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 09/14/2006 | US20060205744 Fused heterocyclic derivatives as ppar modulators |
| 09/14/2006 | US20060205726 e.g. 2-(2-{3-acetoxy-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetoxymethyl)-2-phenylmalonic acid diethyl ester; microsomal triglyceride transfer protein inhibitor in small intestine; antihyperlipidemic, antidiabetic agent; arteriosclerosis, coronary artery diseases, obesity |
| 09/14/2006 | US20060205723 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/14/2006 | US20060205675 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus |
| 09/14/2006 | US20060204587 Use of film coating as taste-masking coating of oral dosage forms |
| 09/14/2006 | CA2601973A1 Process for the preparation of substituted benzoxazole compounds |
| 09/14/2006 | CA2599250A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/13/2006 | EP1700844A1 Phthalic acid diamide derivatives, agricultural and horticultural insecticides and a method for application of the insecticides |
| 09/13/2006 | EP1699769A1 Method of obtaining 2-mercaptobenzothiazole |
| 09/13/2006 | EP1699766A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 09/13/2006 | EP1699752A1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 09/13/2006 | EP1613326B1 (3-{3-'(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino]-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 09/13/2006 | EP1419148B1 M-aminophenol derivatives and colouring agents containing them |
| 09/13/2006 | EP1244621B1 Nitrile derivatives as cathepsin k inhibitors |
| 09/13/2006 | EP1097925B1 Novel benzoic acid derivatives and processes for the preparation thereof |
| 09/13/2006 | EP1087951B9 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1833003A Sulfonamide anions as catalysts for nco oligomerization |
| 09/13/2006 | CN1832944A Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/12/2006 | US7105701 Multibinding compounds for agonists for phenolic derivatives for adrenergic receptors with carriers |
| 09/12/2006 | US7105671 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes |
| 09/12/2006 | US7105670 Intermediates useful in the preparation of diaminothiazoles |
| 09/12/2006 | US7105564 7-(3-{[5-(Pyrrole-1-sulfonyl)-thiophene-2-carbonyl]-amino}-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid; thromboxane A2 receptor and a prostaglandin D2 receptor; for all of eosinophilic infiltration, advance of respiratory anaphylaxis and respiratory contraction |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | US7105554 Benzylidene thiazolidinediones and their use as antimycotic agents |
| 09/12/2006 | US7105553 Thiazolyl amide derivatives |
| 09/12/2006 | US7105552 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 09/12/2006 | US7105551 Thiazole derivatives for treating PPAR related disorders |
| 09/12/2006 | US7105550 2,4-disubstituted thiazolyl derivatives |
| 09/12/2006 | US7105517 N-{4-[2-(1-Dimethylamino-ethylimino)-4-phenyl-thiazol-5-yl]-pyrimidin-2-yl}-N-phenyl-amine; fungicides against infestation by phytopathogenic organisms, nematodes, insects, fungi, bacteria, viruses |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | WO2006094233A1 N,n'-dicyclic isothiourea sirtuin modulators |
| 09/08/2006 | WO2006092049A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 09/08/2006 | CA2599989A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | CA2599843A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 09/07/2006 | US20060199851 Novel compounds that are useful for improving pharmacokinetics |
| 09/07/2006 | US20060199848 Ion channel modulating activity II |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 09/07/2006 | US20060199799 Benzimidazolidinone derivatives as muscarinic agents |
| 09/07/2006 | US20060199223 Chemiluminescent compounds and their use |
| 09/06/2006 | EP1698696A1 Target protein of antidiabetic agent and novel antidiabetic agent insuful corresponding thereto |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1698618A1 Benzamide derivative |
| 09/06/2006 | EP1697339A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 09/06/2006 | EP1697316A1 Novel intermediates for the synthesis of (r)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation |
| 09/06/2006 | EP1697302A1 Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders |
| 09/06/2006 | EP1458697B1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |